Physician

Adam Matthew Meyers, D.O.

According to 2025 Medicare claims, Adam Meyers, D.O. (NPI: 1972554426) practices physical medicine and rehabilitation in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is SEAVIEW ORTHOPAEDICS & MEDICAL ASSOCIATES LLP (NPI: 1982618757; TIN: 222398304) and primary practice location at 07712-7631.

Meyers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 739 traditional Medicare patients, billed 5,885 HCPCS/CPT codes, and received $176,498 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 3,688 prescription claims across 692 beneficiaries totaling $184,043 in drug costs, led by Nucynta (Tapentadol Hcl). 2023 DME data shows 12 claims. Open Payments data shows 32 records totaling $1,608. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $17,103 to $1,568.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	584	3,452	$191,168
2016	710	3,390	$248,660
2017	741	3,280	$223,243
2018	785	2,821	$195,183
2019	688	2,547	$168,568
2020	628	2,414	$154,861
2021	757	3,028	$230,425
2022	730	2,738	$217,691
2023	763	3,215	$204,827
2024	739	5,885	$176,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	367	2,034	$162,406
2016	512	3,014	$307,849
2017	583	3,837	$341,086
2018	641	4,153	$338,500
2019	654	4,263	$348,052
2020	554	3,740	$272,539
2021	603	3,578	$240,175
2022	641	4,024	$263,768
2023	680	3,831	$254,965
2024	692	3,688	$184,043

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	128	368	$17,362
2016	121	381	$12,247
2017	12	148	$1,744
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$169
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	79	98	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	351	589	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	556	876	$66
95885	Needle measurement of electrical activity in arm or leg muscles, limited study	111	123	$51
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	84	90	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucynta	Tapentadol Hcl	34	695	$38,021
Oxycontin	Oxycodone Hcl	45	1,276	$30,393
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	176	5,392	$28,259
Xtampza Er	Oxycodone Myristate	20	600	$7,571
Hysingla Er	Hydrocodone Bitartrate	13	390	$6,749

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$1,608	Pacira Pharmaceuticals Incorporated
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Matthew Meyers, D.O.?

Tedicare shows public-source Medicare data for Adam Matthew Meyers, D.O. (NPI 1972554426), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Matthew Meyers, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Matthew Meyers, D.O.?

Adam Matthew Meyers, D.O. is linked to SEAVIEW ORTHOPAEDICS & MEDICAL ASSOCIATES LLP (billing NPI 1982618757) in the available physician profile data.

Does Adam Matthew Meyers, D.O. have Open Payments data?

Adam Matthew Meyers, D.O. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.